ISTANBUL – In a significant health update, former U.S. President Joe Biden has been diagnosed with an "aggressive form" of prostate cancer that has unfortunately metastasized to his bones. This revelation comes from a statement released by his personal office on Sunday, which has been widely reported by various news outlets.

According to the statement, Biden sought medical attention last week following the discovery of a prostate nodule. During this visit, he was also experiencing increasing urinary symptoms, prompting further investigation by his doctors. The diagnosis was confirmed on Friday, revealing a Gleason score of 9, which indicates a high likelihood of aggressive cancer behavior coupled with metastasis to the skeletal system.

The medical team working with Biden noted that while this diagnosis represents a more severe form of the disease, it is significant that the cancer is categorized as hormone-sensitive. This classification suggests that there are treatment options available that can effectively manage the cancer's progression, potentially improving his prognosis.

At 82 years old, Biden, who served as the President of the United States from 2021 to 2025, is now faced with the challenge of navigating this serious health condition. His office has stated that he and his family are currently in discussions with his medical team to explore the best treatment pathways moving forward. The former president's health has been a topic of concern amongst the public, particularly given his age and the demands of political life.

As more details emerge, the nation watches closely, hoping for a positive outcome and supporting Biden and his family during this challenging time.

This health update not only raises concerns about Biden's well-being but also brings attention to the broader issue of prostate cancer, a prevalent condition affecting many men worldwide. Awareness and early detection remain crucial in battling this disease, emphasizing the importance of regular medical check-ups and understanding the symptoms associated with prostate issues.